# Magseed Pro(R)/ Sentimag(R) Gen3

> **NCT05142787** · NA · RECRUITING · sponsor: **Endomagnetics Ltd.** · enrollment: 224 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Magseed Pro(R) and Sentimag(R) Gen3 by Endomagnetics

## Key facts

- **NCT ID:** NCT05142787
- **Lead sponsor:** Endomagnetics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142787, "Magseed Pro(R)/ Sentimag(R) Gen3". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05142787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*